Stonepine Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Stonepine Capital Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.13M	Buy
2025 Q1	$249K	Buy
2021 Q4	–	Sell
2021 Q3	$3.49M	Hold
2021 Q2	$4.79M	Sell
2021 Q1	$10.8M	Buy
2019 Q4	–	Sell
2019 Q3	$383K	Buy
2018 Q4	–	Sell
2018 Q3	$3.05M	Buy